NCT03675048 - Lactobacillus Reuteri DSM 17938 in Gut Microbiota Development in Infant Born by Caesarean Section | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

October 1, 2018

Primary Completion Date

October 5, 2020

Study Completion Date

December 15, 2020

Conditions

DysbiosisProphylaxis

Interventions

DIETARY_SUPPLEMENT

BioGaia Protectis drops

food supplement containing the patented lactic acid bacterium Lactobacillus reuteri Protectis®/™ (L. reuteri DSM 17938).

DIETARY_SUPPLEMENT

Placebo

Contains same excipients as study drug, without the active ingredient L. Reuteri.

Trial Locations (1)

"State Autonomous Healthcare Institution of the Moscow Region Central clinical hospital of Khimki", Khimki